ロード中...
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations
Drug-induced readthrough over premature stop codons (PTCs) is a potentially attractive therapy for genetic disorders, but a wide outcome variability has been observed. Through expression studies, we investigated the responsiveness to the readthrough-inducing drug geneticin of 11 rationally selected...
保存先:
| 出版年: | Blood |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5408560/ https://ncbi.nlm.nih.gov/pubmed/28196793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-09-738641 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|